Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Rockwell Medical IN (RMTI)

Rockwell Medical IN (RMTI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 81,907
  • Shares Outstanding, K 93,629
  • Annual Sales, $ 62,200 K
  • Annual Income, $ -30,890 K
  • 60-Month Beta 1.02
  • Price/Sales 1.35
  • Price/Cash Flow N/A
  • Price/Book 3.21
Trade RMTI with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.37
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/09/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview

Details
  • Implied Volatility 123.95%
  • Historical Volatility 47.47%
  • IV Percentile 38%
  • IV Rank 12.81%
  • IV High 522.26% on 12/22/20
  • IV Low 65.41% on 06/15/21
  • Put/Call Vol Ratio 0.24
  • Today's Volume 118
  • Volume Avg (30-Day) 317
  • Put/Call OI Ratio 0.10
  • Today's Open Interest 15,682
  • Open Int (30-Day) 14,938

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.08
  • Number of Estimates 1
  • High Estimate -0.08
  • Low Estimate -0.08
  • Prior Year -0.10
  • Growth Rate Est. (year over year) +20.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8400 +4.14%
on 05/25/21
1.0600 -17.47%
on 06/11/21
-0.0202 (-2.26%)
since 05/18/21
3-Month
0.8400 +4.14%
on 05/25/21
1.4300 -38.83%
on 03/19/21
-0.4752 (-35.20%)
since 03/18/21
52-Week
0.8300 +5.40%
on 11/02/20
2.1200 -58.74%
on 07/20/20
-1.1252 (-56.26%)
since 06/18/20

Most Recent Stories

More News
Rockwell Medical Announces Extension of Multi-Year Distribution Agreement with Nipro Medical Corporation for Dialysis Concentrates

Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world,...

RMTI : 0.8748 (-2.62%)
Rockwell Medical and Drogsan Pharmaceuticals Enter into Exclusive License Agreement for the Rights to Commercialize Triferic(R) in Turkey

Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world,...

RMTI : 0.8748 (-2.62%)
Rockwell Medical, Inc. to Present at the 2021 LD Micro Invitational XI

Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world,...

RMTI : 0.8748 (-2.62%)
Rockwell Medical: Q1 Earnings Snapshot

WIXOM, Mich. (AP) _ Rockwell Medical Inc. (RMTI) on Monday reported a loss of $7.8 million in its first quarter.

RMTI : 0.8748 (-2.62%)
Rockwell Medical, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 17, 2021 / Rockwell Medical, Inc. (NASDAQ:RMTI) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 17, 2021 at 4:30 PM...

RMTI : 0.8748 (-2.62%)
Rockwell Medical, Inc. to Report First Quarter 2021 Financial and Operating Results on May 17, 2021

Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world,...

RMTI : 0.8748 (-2.62%)
Rockwell Medical Announces Marketing Approval of Triferic(R) AVNU(TM) in Canada

Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world,...

RMTI : 0.8748 (-2.62%)
Moving Average Crossover Alert: Rockwell Medical (RMTI)

Rockwell Medical (RMTI) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front

RMTI : 0.8748 (-2.62%)
Rockwell Medical Presents Data on Diagnosis and Management of Iron Deficiency Anemia in Home Parenteral Nutrition Patients at the NHIA 2021 Annual Conference

Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world,...

RMTI : 0.8748 (-2.62%)
Rockwell Medical (RMTI) Reports Q4 Loss, Lags Revenue Estimates

Rockwell Medical (RMTI) delivered earnings and revenue surprises of -12.50% and -5.34%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

RMTI : 0.8748 (-2.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Strengthening short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Rockwell Medical Technologies, Inc. manufactures hemodialysis concentrates and dialysis kits, and sells, distributes and delivers such concentrates and dialysis kits, as well as other ancillary hemodialysis products, to hemodialysis providers in the United States. Hemodialysis is a process which is able...

See More

Key Turning Points

3rd Resistance Point 0.9320
2nd Resistance Point 0.9160
1st Resistance Point 0.8954
Last Price 0.8748
1st Support Level 0.8588
2nd Support Level 0.8428
3rd Support Level 0.8222

See More

52-Week High 2.1200
Fibonacci 61.8% 1.6272
Fibonacci 50% 1.4750
Fibonacci 38.2% 1.3228
Last Price 0.8748
52-Week Low 0.8300

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar